Delivery Order 36F79721D0239-36C24526N0675
Award Date 6/24/26
Potential Completion Date 6/26/26
Potential Value $16K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Monroeville, PA 15146, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration awarded a $11,283.90 delivery order against Travere Therapeutics, Inc.'s Pharmaceuticals and Drugs GSA Schedule contract (FSS-61-IB) to provide FILSPARI 200 MG. As part of VHA's mission to provide healthcare services to veterans, this contract will supply the drug from Travere Therapeutics' Bartlett, Tennessee division to VHA's Veterans Integrated Service Network 5 facilities. With a period of performance from December 13-19,...
- This is a federal contract award issued by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Travere Therapeutics, Inc. The contract is for the delivery of the pharmaceutical product Filspari, with a ceiling value of $11,280.64 and a completion date of December 18, 2024. The contract is a Delivery Order under Travere's Federal Supply Schedule (FSS) contract with the VA for Pharmaceuticals and Drugs (FSS-61-IB). Additionally, Travere holds two...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs to Travere Therapeutics, Inc., a biopharmaceutical company specializing in rare disease therapies. The contract provides for the supply of 30 tablets of Sparsentan 400mg, with 7 refills, at a ceiling value of $36,771.30. The order is issued against Travere's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) with the VA, which has a total potential value of up to...
- Travere Therapeutics, Inc. was awarded a $11,280.58 firm fixed price delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The delivery order was issued under Travere's Pharmaceuticals and Drugs General Services Administration Federal Supply Schedule contract to supply FILSPARI to VA medical facilities located in San Diego, California. No set-aside designation was applied to this award. Travere Therapeutics holds several...
- The Department of Veterans Affairs' Veterans Integrated Service Network 5 (VISN 5) awarded a $28,975.20 delivery order to Travere Therapeutics, Inc. for the supply of Thiola 100 mg, a specialized pharmaceutical used to treat cystinuria and related kidney disorders. This award, issued on November 5, 2025, with an ultimate completion date of November 7, 2025, represents a firm fixed-price delivery order issued under Travere's existing Federal Supply Schedule contract for Pharmaceuticals and...
- Travere Therapeutics, Inc. has been awarded a $11,125.32 firm fixed price delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 to supply Thiola 100 MG pharmaceutical products. The delivery order was issued under Travere's Pharmaceuticals and Drugs GSA Schedule contract (FSS-61-IB) with no set-aside applied, and performance will occur in San Diego, California by March 12, 2024. Travere specializes in developing therapies for...
- Travere Therapeutics, Inc. was awarded a $25,983.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order, which has no set-aside designation, is for the delivery of 100 mg Thiola to the place of performance in San Diego, California. The order has a completion date of March 28, 2023 and was awarded on March 24, 2023 under Master GSA...
- This delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awards Travere Therapeutics, Inc. $10,915.75 to provide Thiola medication for patient use. Issued against the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB), this firm fixed price contract has a total small business set aside designation and is to be completed by December 22, 2022. The place of performance is in San Diego, California, where Travere Therapeutics...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $28,372.89 delivery order to Travere Therapeutics, Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The firm fixed price order is for the delivery of THIOLA 100 MG to a location in San Diego, California, with an expected completion date of October 18, 2021. No set-aside designation was used for this award made on October 15, 2021 to supply needed...
- Travere Therapeutics, Inc. was awarded a $18,542.20 firm fixed price delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to supply Thioproin pharmaceutical products. The delivery order was issued under Travere's Pharmaceuticals and Drugs GSA Schedule contract (FSS-61-IB) for products to be delivered to the VA medical facility located in San Diego, California by June 2024. No set-aside designation was applied to this...